Related Experiment Videos
Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities
1Pulmonary Research Institute at Hospital Grosshansdorf, Center for Pneumology and Thoracic Surgery, Woehrendamm 80, 22927 Grosshansdorf, Germany. Magnussen@pulmoresearch.de
Proceedings of the American Thoracic Society
|December 17, 2009
Summary
Systemic inflammation markers are elevated in chronic obstructive pulmonary disease (COPD) and asthma. Physical inactivity and metabolic syndrome contribute to this inflammation, impacting comorbidities in these lung diseases.
Area of Science:
- Pulmonary Medicine
- Immunology
- Internal Medicine
Background:
- Systemic inflammation markers are elevated in patients with chronic obstructive pulmonary disease (COPD) compared to healthy individuals.
- The precise origin of systemic inflammation in COPD remains unclear.
- COPD frequently coexists with other chronic inflammatory conditions like heart failure, diabetes, and arteriosclerosis.
Purpose of the Study:
- To investigate the relationship between systemic inflammation and obstructive lung diseases such as COPD and asthma.
- To explore the role of physical inactivity and metabolic syndrome in systemic inflammation in COPD patients.
- To examine existing data on systemic inflammatory markers in asthma, particularly nonallergic and obese individuals.
Main Methods:
- Review of existing literature on systemic inflammation markers in COPD and asthma.
- Analysis of studies correlating physical inactivity and metabolic syndrome with systemic inflammation in COPD.
- Examination of findings related to systemic inflammation in different asthma phenotypes.
Main Results:
- Elevated systemic inflammation markers are observed in COPD patients.
- Physical inactivity and metabolic syndrome are independently associated with systemic inflammation in COPD.
- Some studies indicate elevated systemic inflammation markers in nonallergic and obese asthma patients.
Conclusions:
- Systemic inflammation is a significant factor in COPD and potentially asthma.
- Physical inactivity and metabolic syndrome are key contributors to systemic inflammation in COPD.
- Further research is needed to clarify the complex interplay between obstructive lung diseases, comorbidities, and systemic inflammation.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: